Position in CADL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$774,673
+$663,159 QoQ
Shares Held
75,211
+281.1% QoQ
Ownership
0.098%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 138 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CADL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $1,234,876,212 across 255 Biotechnology names. CADL ranks #121 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
198,567 | $123,814,467 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
1,191,732 | $88,760,199 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,999 | $70,440,718 | |
| 4 | INSM |
INSMED Inc
|
616,464 | $65,727,391 | |
| 5 | ARGX |
Argenx SE
|
58,400 | $54,181,768 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
422,921 | $46,956,918 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
290,713 | $38,586,336 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
154,605 | $37,842,665 |
All Filings in CADL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $774,673 | 75,211 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $111,514 | 19,737 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $157,906 | 30,962 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $186,972 | 36,951 | Shares | Defined | 2025-08-27 | |
| 2025-03-31 | $424,190 | 75,078 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $167,619 | 19,311 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $71,718 | 10,349 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $75,875 | 12,238 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||